Dr. Michael Maccini

Dr. Michael Maccini
Dr. Maccini was raised just north of Spokane and graduated from Mount Spokane High School before attending Dartmouth College in Hanover, New Hampshire. He then graduated with Alpha Omega Alpha honors from medical school at the Larner College of Medicine at the University of Vermont in Burlington, Vermont. Dr. Maccini completed his six-year urologic residency at the University of Colorado Hospital, Denver Health Medical Cenver (a Level I trauma center), Children’s Hospital Colorado, and the VA Medical Center in Denver. Dr. Maccini treats a wide spectrum of urologic conditions, including urinary incontinence, erectile dysfunction, kidney stones, and prostate, bladder, and testicular cancer. He has a special focus in his practice on providing the full spectrum of treatment options for enlarged prostate (BPH) symptoms, including Aquablation which demonstrates great urinary improvement outcomes and preserves patients' sexual function better than many other prostate procedures. Dr. Maccini views patient understanding and education as the foundation of effective and personalized health care. He strives to make a positive impact on patients’ quality of life and general wellness.
Medical School:

University of Vermont Larner College of Medicine

Residency:

University of Colorado

Undergraduate:

Dartmouth College

Locations

Spokane Urology Spokane, Washington

1401 E Trent Ave, Suite 200Spokane, Washington, 99202United States
509-747-3147 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only